Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Medical - Pharmaceuticals

Healthcare
$13.31 +5.43%

+$0.76 today

Market cap
$800.64M
Beta
0.00
52W Low $13.50High $25.93

Volume 0.21M

Average 0.38M

LTGO EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

No reported EBITDA figures are available to summarize.

EBITDA history

Currency unavailable · from the income statement

No EBITDA data reported for this period type.

EBITDA vs competitors

How LTGO compares with its peers on the latest reported figures

LTGO Competitors
EBITDA for LTGO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$609.91M USD+83.3%+32.3%76.6%
PCRXPacira BioSciences, Inc.LTM Mar 2026$118.4M USD+322.5%-4.4%16.1%
SCLXScilex Holding CompanyLTM Mar 2026-$374.35M USD-462.2%—1105.5%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding LTGO) —+83.3%+13.9%76.6%

Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Latigo Biotherapeutics Inc.

NASDAQ:LTGO

Intrinsic Alpha fair value

Locked

Current Price

$13.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.